Beneficial Effects of ε-Viniferin on Obesity and Related Health Alterations
Nutrients · 2023
DOI: 10.3390/nu15040928 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2023. Verfasst von Saioa Gómez-Zorita und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition and Obesity Group, Department of Nutrition and Food Science, Faculty of Pharmacy and Lucio Lascaray Research Centre, University of the Basq…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Stilbenes, Vitis. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition, Basque Government, CIBEROBN.
Abstract (Originalsprache)
Viniferin is a phenolic compound belonging to the group of stilbenoids. In particular, ε-viniferin is a dimer of resveratrol, found in many plant genders, among which grapes (Vitis vinifera) are a primary source. Due to the fact that ε-viniferin is mainly present in the woody parts of plants, their use as a source of this bioactive compound is a very interesting issue in a circular economy. Both, in vitro studies carried out in pre-adipocytes and mature adipocytes and in vivo studies addressed in mice show that ε-viniferin is able to reduce fat accumulation. Moreover, it prevents the development of some obesity co-morbidities, such as type 2 diabetes, dyslipidemias, hypertension and fatty liver. ε-viniferin can be absorbed orally, but it shows a very low bioavailability. In this scenario, further research on animal models is needed to confirm the effects reported in a great number of studies; to determine which metabolites are involved, including the main one responsible for the biological effects observed and the mechanisms that justify these effects. In a further phase, human studies should be addressed in order to use ε-viniferin as a new tool for obesity management, as a nutraceutical or to be included in functional foods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nutrition and Obesity Group, Department of Nutrition and Food Science, Faculty of Pharmacy and Lucio Lascaray Research Centre, University of the Basque Country (UPV/EHU), 01006 Vitoria-Gasteiz, Spain.
- CIBERobn Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, 28222 Madrid, Spain.
- BIOARABA Health Research Institute, 01006 Vitoria-Gasteiz, Spain.
- Univ. Bordeaux, Bordeaux INP, INRAE, OENO, UMR 1366, ISVV, F-33140 Villenave d'Ornon, France.
- Bordeaux Sciences Agro, Bordeaux INP, INRAE, OENO, UMR 1366, ISVV, F-33170 Gradignan, France.
- Centre Antipoison de Nouvelle Aquitaine, CHU de Bordeaux, 33076 Bordeaux, France.
ORCID-Profile: Saioa Gómez-Zorita, Iñaki Milton-Laskibar, Arnaud Courtois, Stéphanie Krisa, María P Portillo
Förderung
- Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition
- Basque Government
- CIBEROBN
- Government of the Basque Country
Zitieren
APA
Gómez-Zorita, S., Milton-Laskibar, I., Eseberri, I., Beaumont, P., Courtois, A., Krisa, S., & Portillo, M. P. (2023). Beneficial Effects of ε-Viniferin on Obesity and Related Health Alterations. Nutrients. https://doi.org/10.3390/nu15040928
Vancouver
Gómez-Zorita S, Milton-Laskibar I, Eseberri I, Beaumont P, Courtois A, Krisa S, et al. Beneficial Effects of ε-Viniferin on Obesity and Related Health Alterations. Nutrients. 2023. doi:10.3390/nu15040928
BibTeX
@article{GmezZorita2023,
author = {Gómez-Zorita, Saioa and Milton-Laskibar, Iñaki and Eseberri, Itziar and Beaumont, Pauline and Courtois, Arnaud and Krisa, Stéphanie and Portillo, María P},
title = {Beneficial Effects of ε-Viniferin on Obesity and Related Health Alterations},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15040928}
}
EUVIMED